End‐Of‐Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition is a research paper published in Cancer Medicine (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 2T32CA217834‐07
National Cancer Institute
Grant: 5P30CA068485‐27
NIH HHS
Grant: 2T32CA217834-07
NCI NIH HHS
Grant: 5P30CA068485-27
MeSH Terms
Keywords